Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 46-3250612

EVIDENCE FOR HEALTHCARE IMPROVEMENT

Also known as INSTITUTE FOR CLINICAL AND ECONOMIC

Tax-exempt · BOSTON, MA 02108

Financials

$6.7M$8.8M2023$9.2M$8.9M2024
Revenue Expenses · by fiscal year end
Financials of EVIDENCE FOR HEALTHCARE IMPROVEMENT by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$9,211,502$8,945,426$266,076$11,859,724$6,556,957$5,302,767
December 31, 2023990$6,693,676$8,783,710-$2,090,034$12,213,931$7,177,240$5,036,691
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$7,529,956
Program service revenue
$1,269,012
Investment income
$200,884
Net rental income
$210,718
Other revenue
$211,650

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$2,012,157
Other salaries and wages
$2,418,607
Salaries, compensation and benefits (total)
$5,067,881
Professional fundraising fees
$0
Legal fees
$36,374
Accounting fees
$28,552
Occupancy
$741,642
Travel
$186,686
Depreciation
$342,333
Program services (functional)
$6,918,823
Management and general (functional)
$1,913,292
Fundraising (functional)
$113,311

Balance sheet and other

Total assets, start of year
$12,213,931
Total assets, end of year
$11,859,724
Total liabilities, end of year
$6,556,957
Net assets, end of year
$5,302,767
Land, buildings and equipment
$1,268,161
Net assets without donor restrictions
$5,302,767
Gross receipts
$9,211,502
Employees
36
Volunteers
9
Year formed
2013
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
SARAH K EMONDPRESIDENT & CEO
Officer
40$441,006$84,919
DAVID RINDCHIEF MEDICAL OFFICER
Key employee
32$325,251$100,537
DANIEL OLLENDORFCHIEF SCIENTIFIC OFFICER
Key employee
32$322,667$44,095
ELLIE ADAIRCOO & SECRETARY /TREASURER
Officer
40$260,393$44,823
FOLUSO AGBOOLAVP OF RESEARCH
Key employee
40$205,364$71,332
MARIA LOWEDIRECTOR OF PHARMACEUTICAL INTELLIGENCE
Key employee
40$167,465$61,564
ANITA CHANFINANCE DIRECTOR
Highest-paid employee
40$137,724$55,543
LIIS SHEASENIOR PROGRAM DIRECTOR
Highest-paid employee
40$141,087$47,085
AMANDA MEHLMANDIRECTOR OF STRATEGIC PARTNERSHIPS
Highest-paid employee
40$132,958$39,429
MAX LEEPHARMACEUTICAL INTELLIGENC
Highest-paid employee
40$128,892$33,614
ABIGAIL WRIGHTDIRECTOR, EVIDENCE SYNTHESIS
Highest-paid employee
40$128,056$31,338
LEIGH PURVIS MPABOARD CHAIR
Trustee or director, Officer
1$0$0
ELLEN ANDREWS PHDDIRECTOR
Trustee or director
1$0$0
LINDA GOLER BLOUNT MPHDIRECTOR
Trustee or director
1$0$0
HENRY CLAYPOOLDIRECTOR
Trustee or director
1$0$0
5 more people on this return
NameTitleHours / weekCompensation
ROBERTA HERMAN MDDIRECTOR
Trustee or director
1$0
CHRIS JENNINGSDIRECTOR
Trustee or director
1$0
JOY LEWIS MSW MPHDIRECTOR
Trustee or director
1$0
ANYA RADER WALLACK PHDDIRECTOR
Trustee or director
1$0
MARK SKINNER JDDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2023: 20 people
NameTitleHours / weekCompensationOther / benefits
STEVEN D PEARSONPRESIDENT
Officer
40$555,239$46,392
SARAH K EMONDPRESIDENT-ELECT
Officer
40$382,269$39,604
DAVID RINDCHIEF MEDICAL OFFICER
Key employee
32$305,856$46,114
ELLIE ADAIRCOO
Officer
40$220,177$11,479
FOLUSO AGBOOLAVP OF RESEARCH
Key employee
40$188,864$40,956
JONATHAN CAMPBELLSR VP HEALTH ECON. UNTIL 7/23
Key employee
40$180,947$27,486
MARIA LOWEDIR. OF PHARMA. INTELLIGENCE
Highest-paid employee
40$148,710$29,566
MAX LEEPHARMACEUTICAL INTELLIGENCE MGR
Highest-paid employee
40$119,523$11,249
MEAGHAN CUMMINGSSPECIAL ASSISTANT TO THE PRESIDENT
Highest-paid employee
40$113,850$16,252
ANITA CHANFINANCE DIRECTOR
Highest-paid employee
40$111,956$16,615
CATHERINE KOOLA FISCHERDIR. OF PATIENT ENGAGEMENT
Highest-paid employee
40$106,446$15,202
LINDA GOLER BLOUNT MPHDIRECTOR
Trustee or director
1$1,500$0
LEIGH PURVIS MPABOARD CHAIR
Trustee or director, Officer
1$0$0
ELLEN ANDREWS PHDDIRECTOR
Trustee or director
1$0$0
ROBERTA HERMAN MDDIRECTOR
Trustee or director
1$0$0
CHRIS JENNINGSDIRECTOR
Trustee or director
1$0$0
JOY LEWIS MSW MPHDIRECTOR
Trustee or director
1$0$0
MURRAY ROSS PHDDIRECTOR
Trustee or director
1$0$0
ANYA RADER WALLACK PHDDIRECTOR
Trustee or director
1$0$0
MARK SKINNER JDDIRECTOR
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
14 BEACON STREET STE 800, BOSTON, MA 02108-3704
In care of
% NIXON PEABODY LLP
Principal officer (990 for 2024)
SARAH EMOND, 14 BEACON STREET STE 800, BOSTON, MA 02108
Signed the 990
ELLIE ADAIR, COO
Phone
(617) 528-4013
Website
ICER.ORG
Return prepared by
CLIFTONLARSONALLEN LLP

Mission

ICER SEEKS TO PROVIDE AN INDEPENDENT SOURCE OF EVIDENCE - FREE FROM FINANCIAL CONFLICTS OF INTEREST TO HELP PATIENTS TODAY AND IN THE FUTURE BY CATALYZING A MOVEMENT TOWARD FAIR PRICING, FAIR ACCESS, AND FUTURE INNOVATION ACROSS THE ENTIRE US HEALTH CARE SYSTEM.

990 for the year ended December 31, 2024

Program accomplishments

  • ICER'S PROGRAM TO EVALUATE NEW TECHNOLOGIES, INCLUDING NEW DRUGS AT OR NEAR THE TIME OF FDA APPROVAL, PROVIDES AN INDEPENDENT ANALYSIS OF THE COMPARATIVE EFFECTIVENESS OF NEW TECHNOLOGIES, ALONG WITH AN ASSOCIATED HEALTH-BENEFIT PRICE BENCHMARK, WITH THE OBJECTIVE OF HELPING DECISION-MAKERS UNDERSTAND AND APPLY EVIDENCE TO IMPROVE VALUE THROUGHOUT THE HEALTH CARE SYSTEM. THE ROBUST RESEARCH CONDUCTED TO PRODUCE REPORTS FOR THE TECHNOLOGY ASSESSMENT PROGRAM IS COMPLEMENTED BY AN EXTENSIVE PATIENT AND STAKEHOLDER ENGAGEMENT PROGRAM THAT ENSURES THAT THE EXPERIENCE OF PATIENTS AND THEIR FAMILIES ARE AT THE CENTER OF THE WORK. THE REPORTS OF THE TECHNOLOGY ASSESSMENT PROGRAM ARE VETTED THROUGH THREE REGIONAL COLLABORATIVES OF INDEPENDENT EXPERTS IN THE EVALUATION AND APPLICATION OF EVIDENCE: THE CALIFORNIA TECHNOLOGY ASSESSMENT FORUM (CTAF), THE MIDWEST COMPARATIVE EFFECTIVENESS PUBLIC ADVISORY COUNCIL (MIDWEST CEPAC), AND THE NEW ENGLAND COMPARATIVE EFFECTIVENESS PUBLIC ADVISORY COUNCIL (NEW ENGLAND CEPAC). FOR EACH PANEL, INDEPENDENT CLINICIANS, METHODOLOGISTS, AND PUBLIC REPRESENTATIVES CONVENE SEVERAL TIMES A YEAR AT PUBLIC MEETINGS TO REVIEW OBJECTIVE EVIDENCE REPORTS PRODUCED BY ICER AND TO DEVELOP RECOMMENDATIONS FOR HOW STAKEHOLDERS CAN APPLY EVIDENCE TO IMPROVE THE QUALITY AND VALUE OF HEALTH CARE. ALL THREE PANELS DIRECTLY ENGAGE CLINICIANS, PATIENTS, AND PAYERS DURING THESE PUBLIC MEETINGS TO DISCUSS APPLICATION OF THE EVIDENCE FOR CLINICAL DECISION-MAKING, BENEFIT DESIGN, AND PATIENT AND CLINICIAN TOOLS TO IMPROVE CLINICAL CARE AND PATIENT OUTCOMES.
    Expenses $5,858,649 · revenue $24,530
  • ICER ANALYTICS IS A CLOUD-BASED PLATFORM THAT FACILITATES THE USE OF ICER'S EVIDENCE REPORTS AND UNDERLYING ANALYSES TO HELP ALL AMERICANS ACHIEVE SUSTAINABLE ACCESS TO HIGH-VALUE CARE. AVAILABLE ON A SUBSCRIPTION BASIS, THE PLATFORM PROVIDES PHARMACEUTICAL MANUFACTURERS, PRIVATE AND PUBLIC PAYERS, CLINICIANS, PATIENTS, AND OTHER STAKEHOLDERS, WITH A SUITE OF TOOLS THAT STREAMLINE INTERPRETATION OF ICER'S ANALYSES, DIRECTLY FROM THE SOURCE, ALL DESIGNED TO SUPPORT INTEGRATION INTO USERS' OWN PRICING, REIMBURSEMENT, AND CLINICAL WORK. ICER ANALYTICS SUBSCRIBERS HAVE ACCESS TO ICER'S PRICE BENCHMARKS, COST-EFFECTIVENESS RESULTS, COMPARATIVE CLINICAL EFFECTIVENESS JUDGMENTS, POLICY RECOMMENDATIONS, AND ECONOMIC MODELS WITHIN TWO PRIMARY TOOLS THE EVIDENCE COMPENDIUM AND THE INTERACTIVE MODELER.
    Expenses $602,043 · revenue $768,157
  • THE POLICY LEADERSHIP FORUM ("PLF") WAS LAUNCHED TO GIVE A SELECT NUMBER OF LEADING HEALTH CARE ORGANIZATIONS A UNIQUE OPPORTUNITY TO SHAPE THE FUTURE OF EVIDENCE AND COVERAGE POLICY IN THE UNITED STATES. THE TENSION BETWEEN INNOVATION AND HEALTH CARE COSTS CONTINUES TO FOCUS CRITICAL ATTENTION ON HOW EVIDENCE WILL BE DEVELOPED BY MANUFACTURERS AND HOW IT WILL BE INTERPRETED BY PAYERS IN MAKING COVERAGE DECISIONS. BENEFITING FROM ICER'S EXPERIENCE AS A LEADER IN HEALTH TECHNOLOGY ASSESSMENT, AND ITS UNIQUE ABILITY TO SERVE AS AN ENGAGED, OBJECTIVE CONVENER AND MODERATOR, PLF BRINGS TOGETHER A SMALL, INFLUENTIAL GROUP OF EVIDENCE LEADERS FROM INSURERS, PHARMACY BENEFIT MANAGEMENT FIRMS, HEALTH TECHNOLOGY ASSESSMENT GROUPS, AND LIFE SCIENCE COMPANIES TO ADDRESS KEY CONTROVERSIES IN EVIDENCE METHODS AND POLICY. WORKING TOGETHER IN A BALANCED, NONADVERSARIAL ENVIRONMENT, PLF MEMBERS CONTRIBUTE TO THE DEVELOPMENT OF INFLUENTIAL POLICY RECOMMENDATIONS WHILE ENHANCING THE SKILLS, INSIGHTS, AND RELATIONSHIPS NECESSARY TO STRENGTHEN THEIR COMPETITIVE POSITION IN THE MARKETPLACE. DUES FROM PLF MEMBERS SUPPORT ICER'S ANNUAL POLICY SUMMIT AND DO NOT CONTRIBUTE TO FUNDING FOR ICER'S VALUE ASSESSMENTS.
    Expenses $458,131 · revenue $476,325

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
46-3250612
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2014
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E99)
Assets (IRS master file)
$11,859,724
Income (IRS master file)
$9,211,502

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$9,211,502$8,945,426$11,859,724XML
990December 2023$6,693,676$8,783,710$12,213,931XML
990December 2022$9,203,334$9,318,450$15,511,951IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 46-3250612).

Questions about EVIDENCE FOR HEALTHCARE IMPROVEMENT

What is the EIN of EVIDENCE FOR HEALTHCARE IMPROVEMENT?
The employer identification number (EIN) of EVIDENCE FOR HEALTHCARE IMPROVEMENT is 46-3250612.
Is EVIDENCE FOR HEALTHCARE IMPROVEMENT tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2014.
Are donations to EVIDENCE FOR HEALTHCARE IMPROVEMENT tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does EVIDENCE FOR HEALTHCARE IMPROVEMENT file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of EVIDENCE FOR HEALTHCARE IMPROVEMENT due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did EVIDENCE FOR HEALTHCARE IMPROVEMENT last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of EVIDENCE FOR HEALTHCARE IMPROVEMENT?
The 990 for the year ended December 31, 2024 names SARAH EMOND.
Who are the officers and directors of EVIDENCE FOR HEALTHCARE IMPROVEMENT?
The 990 for the year ended December 31, 2024 lists 20 people; 11 received compensation from the organization, the highest $441,006 (SARAH K EMOND, PRESIDENT & CEO).
How much revenue does EVIDENCE FOR HEALTHCARE IMPROVEMENT have?
On its 990 for the year ended December 31, 2024 it reported revenue of $9,211,502, expenses of $8,945,426 and total assets of $11,859,724 at year end.

Other nonprofits in BOSTON

All nonprofits in BOSTON · Massachusetts · Health care